COMPLETE annual coverage of the entire population by vaccination against influenza is undoubtedly unrealistic (Cockburn, 1973; Davenport, 1973; Marcus, Liem and Andre, 1974) . Therefore the uses suggested for influenza virus vaccines are predicated by the objectives. The excess of general mortality speaks for itself (Langmuir and Housworth, 1969) . To prevent deaths, in the majority of the countries, about 20-25% of the population must be vaccinated for coverage of high-risk groups (Davenport, 1973) . Even if the goal of annual vaccination of the highrisk group is attained, it is unlikely that the spread of an epidemic will be significantly influenced.
The effect of influenza virus infection on the outcome of a pregnancy Jessop, 1959, 1963; Barret-Connor, 1969 ) and the excess of neonatal and under one year of age mortality is increasingly recognized (Wynne-Griffith et al., 1972) . Data on industrial losses, and the costs of epidemic influenza have been estimated and are now becoming available (Davenport, 1973) . The public is becoming more aware of the ravages of influenza, and the demand that something be done is increasingly heard. These observations require that appropriate priorities should be established at the national level.
Epidemiological studies in naturally infected persons have shown that there is a significant relationship between circulating antibody levels (geometric means) to the current virus and morbidity, although now and then some individual exception may be noted. This is strongly supported by the correlation between monthly clinical influenza incidence and the serological survey of the population (Fig. 1) , the latter being a more sensitive indicator of influenza outbreaks.
The age distribution of epidemic influenza is consistently expressed by the comparative morbidity in different age groups (Fig. 2) . The major prevalence of clinical disease is more common in the age group 1 month to 14 years and especially in the age group of 5-14 years. After 15 years of age, there is usually a distinct progressive decrease in incidence.
These data are in agreement with classical data (Davenport, 1973) and with the serological survey (Fig. 3) , the geometric mean titres in the 5-14 age group being commonly greater than in other groups. Moreover our serological findings support those of Jordan (1960) and of Mulder and Masurel (1958) 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 Influenza morbidity by age groups in Rumania (1961) (1962) (1963) (1964) (1965) (1966) (1967) (1968) (1969) (1970) (1971) (1972) (1973) (Coffey and Jessop, 1959) and (2) can be no lack of metabolites arising from the damaged mucosa of the respiratory tract or even from the virus itself. Thus, metabolites which produced systemic reaction were reported by Bourne and Wedgwood (1959) and Skanse and Miorner (1959) in connection with the epidemic of Asian influenza.
It is possible to suppose that some of these substances could cross the placenta and interfere with the development of the embryo, and to provoke abortion, stillbirth or premature delivery.
In view of these data, it seems logical to utilize the available vaccine for the protection of infacts, school children and pregnant women. Their vaccineinduced protection can offer significant, although not total, protection to the whole population and prevent obstetrical accidents. 
